Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy

Amyloid

Volumn 10, Issue 4, 2003, Pages 229-239

  Hattori, Takeshi ^a   Takei, Yo Ichi ^a   Koyama, Jun ^a   Nakazato, Masamitsu ^b   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PREALBUMIN;

ADULT; AGE DETERMINATION; AGED; AGING; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; GENE MUTATION; HEART AMYLOIDOSIS; HEART WEIGHT; HOSPITAL ADMISSION; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 1642476795     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506120309041740     Document Type: Article

References (47)

1. Connors LH, Richardson AM, Theberge R and Costello CE (2000). Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid: Int J Exp Clin Invest 7, 54-69
2. Ikeda S, Nakazato M, Ando Y and Sobue G (2002). Familial transthyretin type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 58, 1001-1007
3. Plehn JF and Friedman BJ (1989). Diastolic dysfunction in amyloid heart disease: restrictive cardiomyopathy or not? J Am Coll Cardiol 13, 54-56
4. Freitas AFDe and A Barbedo (1978). Conduction disturbances in 190 patients with familial amyloidotic polyneuropathy (Andrade's type). Adv Cardiol 21, 206-209
5. Sawayama T, Kurihara T and Araki S (1978). Noninvasive cardiovascular findings in familial amyloid polyneuropathy. Br Heart J 40, 1288-1292
6. Olofsson BO, Andersson R and Furberg B (1980). Atrioventricular and intraventricular conduction in familial amyloidosis with polyneuropathy. Acta Med Acand 208, 77-80
7. Takahashi K, Sakashita N, Ando Y, Suga M and Ando M (1997). Late onset type I familial amyloidotic polyneuropathy: presentation of three autopsy cases in comparison with 19 cases of the ordinary type. Pathol Int 47, 353-359
8. Nakamura Y, Yutani C, Nakazato M, Date Y, Baba T and Goto Y (1999). A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells. Pathol Int 49, 898-902
9. 55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Hum Genet 89, 353-356
10. Takahashi N, Ueno S, Uemichi T, Fujimura H, Yorifuji S and Tarui S (1992). Amyloid polyneuropathy with transthyretin Arg50 in a Japanese case from Osaka. J Neurol Sci 112, 58-64
11. Hesse A, Altland K, Linke RP, Almeida MR, Saraiva MJM, Steinmetz A and Maisch B (1993). Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant. Br Heart J 70, 111-115
12. Yazaki M, Takei Y, Katoh M and Ikeda S (2000). Postmortem findings in two familial amyloidosis patients with transthyretin variant Asp38Ala. Amyloid: Int J Exp Clin Invest 7, 270-277
13. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D and Falk RH ( 1997). Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 64, 74-80
14. Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys MB and Williams R (1998). Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy. Transplantation 66, 229-233
15. Garcia-Herola A, Prieto M, Pascual S, Berenguer M, Lopez-Viedma B, Mir J, Vilchez JJ and Berenguer J (1999). Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant. Liver Transpl Surg 5, 246-248
16. Ikeda S, Nakano T, Yanagisawa N, Nakazato M and Tsukagoshi H (1992). Asymptomatic homozygous gene carrier in a family with type I familial amyloid polyneuropathy. Eur Neurol 32, 308-313
17. Tachibana N, Tokuda T, Yoshida K, Taketomi T, Nakazato M, Li Y-F, Masuda Y and Ikeda S (1999). Usefulness of MALD-TOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid: Int J Exp Clin Invest 6, 282-288.
18. Kito S, Itoga E, Kamiya K, Kishida T and Yamamura Y (1980). Studies on familial amyloid polyneuropathy in Ogawa Village. Eur Neurol 19, 141-151
19. Misu K, Hattori N, Nagamatsu M, Ikeda S, Ando Y, Nakazato M, Takei Y, Hanyu N, Usui Y, Tanaka F, Harada T, Inukai A, Hashizume Y and Sobue G (1999). Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain 122, 1951-1962
20. Westermark P, Araki S, Benson MD, Cohen AS, Frangione B, Masters CL, Saraiva MJ, Sipe JD, Husby G, Kyle RA and Selkoe D (1999). Nomencalture of amyloid fibril protein. Amyloid: Int J Exp Clin Invest 6, 63-66
21. Sigueira-Filho AG, Cunha CLP, Tajik AJ, Seward JB, Schattenberg TT and Giuliani ER (1981). M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation 63, 188-196
22. Hongo M and Ikeda S (1986). Echocardiographic assessment of the evolution of amyloid heart disease: a study with familial amyloid polyneuropathy. Circulation 73, 249-256
23. Wizenberg TA, Muz J, Sohn YH, Samlowski W and Weissler AM (1982). Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis. Am Heart J 103, 468-473
24. Hongo M, Hirayama J, Fujii T, Yamada H, Okubo S, Kusama S and Ikeda S (1987). Early identification of amyloid heart disease by technetium-99m- pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy. Am Heart J 113, 654-662
25. Roberts WC and Waller BF (1983). Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. Am J Cardiol 52, 137-146
26. Andrade C (1952). A peculiar form of peripheral neuropathy: familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 110, 408-427
27. Andersson R (1976). Familial amyloidosis with polyneuropathy. A clinical study on patients living in northern Sweden. Acta med scand Suppl 590, 1-64
28. Araki S, Mawatari S, Ohta M, Nakajima A and Kuroiwa Y (1968). Polyneuritic amyloidosis in a Japanese family. Arch Neurol 18, 593-602
29. Ikeda S, Hanyu N, Hongo M, Yoshioka J, Oguchi H, Yanagisawa N, Kobayashi T, Tsukagoshi H, Ito N and Yokota T (1987). Hereditary generalized amyloidosis with polyneuropathy. Clinicopathological study of 65 Japanese patients. Brain 110, 315-337
30. Eriksson P, Backman C, Eriksson A, Eriksson S, Kapp K and Olofsson B-O (1987). Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. Acta Med Scand 221, 39-46
31. Eriksson P, Backman C, Bjerle P, Eriksson A, Holm S and Olofsson B-O (1984). Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m-pyrophospahte scintigraphy. Br Heart J 52, 321-326
32. Rukavina JG, Block WD, Jackson CE, Falls HF, Cary JH and Curtis AC (1956). Primary systemic amyloidosis: a review and an experimental genetic and clinical study of 29 cases with particular emphasis on the familial form. Medicine 35, 239-334
33. Benson MD, Wallace MR, Tejada E, Baumann H and Page B (1987). Hereditary amyloidosis: description of a new American kindred with late onset cardiomyopathy, Appalachian amyloid. Arthritis Rheum 30, 195-200
34. Connors LH, Theberge R, Skare J, Costello CE, Falk RH and Skinner M (1999). A new transthyretin variant (Ser23Asn) associated with familial amyloidosis in a Portuguese patient. Amyloid: Int J Exp Clin Invest 6, 114-118
35. Dupuy O, Bletry O, Blanc A-S, Droz D, Viemont M, Delpech M and Grateau G (1998). A novel variant of transthyretin (Glu42Asp) associated with sporadic late-onset cardiac amyloidosis. Amyloid: Int J Exp Clin Invest 5, 285-287
36. Janunger T, Anan I, Holmgren G, Lovheim O, Ohlsson P-I, Suhr OB and Tashima K (2000). Heart failure caused by a novel amyloidogenic mutation of the transthyretin gene: ATTR Ala45Ser. Amyloid: Int J Exp Clin Invest 7, 137-140
37. Nishi H, Kimura A, Harada H, Hayashi Y, Nakamura M and Sasazuki T (1992). Novel variant transthyretin gene (Ser50 to Ile) in familial cardiac amyloidosis. Biochem Biophys Res Commun 187, 460-466
38. Almeida MR, Hesse A, Steinmetz A, Maisch B, Altlamd K, Linke RP, Gawinowicz MA and Saraiva MJM (1991). Transthyretin Leu 68 in a form of cardiac amyloidosis. Basic Res Cardiol 86, 567-571
39. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS and Buxbaum JN (1997). Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 336, 466-473
40. 30→Leu) associated with familial amyloidotic polyneuropathy. FEBS Lett 306, 206-208
41. 30→Leu). Brain Nerve 48, 175-178. (in Japanese)
42. 55→Pro). Muscle Nerve 17, 637-641
43. Kotani N, Hattori T, Yamagata S, Tokuda T, Shirasawa A, Yamaguchi S, Kobayashi S and Ikeda S (2001). Transthyretin Thr60Ala Appalachian-type mutation in a Japanese family with familial amyloidotic polyneuropathy. Amyloid: J Protein Folding Disord 9, 31-34
44. Takei Y, Hattori T, Yazaki M, Tokuda T, Urasawa N, Kanai S, Ikeda S (2003). Transthyretin Tyr69-to-Ile mutation (double-nucleotide substitution in codon 69) in a Japanese familial amyloidosis patient with cardiomyopathy and carpal tunnel syndrome. Amyloid: J Protein Folding Disord 10, 25-28
45. 97 to Gly). J Neurol Sci 121, 97-102
46. Ueno S, Fujimura H, Yorifuji S, Nakamura Y, Takahashi M, Tarui S and Yanagihara T (1992). Familial amyloid polyneuropathy associated with the transthyretin Cys 114 gene in a Japanese kindred. Brain 115, 1275-1289
47. Mochizuki H, Kamakura K, Masaki T, Hirata A, Tokuda T, Yazaki M, Motoyoshi K and Ikeda S (2001). Nodular cutaneous amyloidosis and carpal tunnel syndrome due to the amyloidogenic transthyretin His 114 variant. Amyloid: J Protein Folding Disord 8, 105-110